Nuveen Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-139,752
| Closed | -$1.26M | – | 3464 |
|
|
2024
Q1 | $1.26M | Hold |
139,752
| – | – | ﹤0.01% | 2597 |
|
|
2023
Q4 | $1.52M | Buy |
139,752
+1,475
| +1% | +$16K | ﹤0.01% | 2535 |
|
|
2023
Q3 | $1.11M | Sell |
138,277
-1,200
| -0.9% | -$9.66K | ﹤0.01% | 2530 |
|
|
2023
Q2 | $1.51M | Buy |
+139,477
| New | +$1.51M | ﹤0.01% | 2474 |
|
|
2022
Q2 | – | Sell |
-111,914
| Closed | -$1.05M | – | 3450 |
|
|
2022
Q1 | $1.05M | Buy |
111,914
+1,363
| +1% | +$12.7K | ﹤0.01% | 2806 |
|
|
2021
Q4 | $1.31M | Sell |
110,551
-8,772
| -7% | -$104K | ﹤0.01% | 2752 |
|
|
2021
Q3 | $1.36M | Sell |
119,323
-9,133
| -7% | -$104K | ﹤0.01% | 2852 |
|
|
2021
Q2 | $736K | Buy |
128,456
+42,482
| +49% | +$243K | ﹤0.01% | 3104 |
|
|
2021
Q1 | $1.33M | Buy |
85,974
+2,073
| +2% | +$32.1K | ﹤0.01% | 2789 |
|
|
2020
Q4 | $1.02M | Sell |
83,901
-4,682
| -5% | -$57.1K | ﹤0.01% | 2797 |
|
|
2020
Q3 | $1.14M | Buy |
88,583
+12,459
| +16% | +$160K | ﹤0.01% | 2632 |
|
|
2020
Q2 | $773K | Sell |
76,124
-76,939
| -50% | -$781K | ﹤0.01% | 2728 |
|
|
2020
Q1 | $1.24M | Buy |
153,063
+55,116
| +56% | +$448K | ﹤0.01% | 2413 |
|
|
2019
Q4 | $847K | Buy |
97,947
+19,423
| +25% | +$168K | ﹤0.01% | 2743 |
|
|
2019
Q3 | $484K | Buy |
78,524
+31,825
| +68% | +$196K | ﹤0.01% | 2957 |
|
|
2019
Q2 | $776K | Buy |
+46,699
| New | +$776K | ﹤0.01% | 2839 |
|